Remimazolam Besylate is named as a drug or biological intervention in 2 clinical trials in our China trial register, 2 of which are recruiting. Lead sponsors include Beijing Shijitan Hospital, Capital Medical University (1) and Qianfoshan Hospital (1). Registered phases: Phase 4 and Phase 1. Conditions studied include Effect of Drug; Adverse Drug Event; Mechanical Ventilation Complication.
| NCT ID | Study | Phase | Status |
|---|---|---|---|
| NCT06575530 | Efficacy and Safety of Remimazolam Besylate for Sedation in Post-Non-Cardiac Surgery Patients Requiring Mechanical Ventilation (ClinicalTrials.gov ↗) Effect of Drug, Adverse Drug Event, Mechanical Ventilation Complication |
Phase 4 | Recruiting |
| NCT07045467 | Remimazolam Infusion in Kidney Transplant Patients: A Multicenter Study (ClinicalTrials.gov ↗) Chronic Kidney Diseases, Renal Transplantation |
Phase 1 | Recruiting |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Trial titles and statuses are copied from the registry as published.
| Condition (as registered) | Trials |
|---|---|
| Effect of Drug | 1 |
| Adverse Drug Event | 1 |
| Mechanical Ventilation Complication | 1 |
| Critical Illness | 1 |
| Chronic Kidney Diseases | 1 |
| Renal Transplantation | 1 |
| Lead sponsor | Trials |
|---|---|
| Beijing Shijitan Hospital, Capital Medical University | 1 |
| Qianfoshan Hospital | 1 |
| Register | Remimazolam Besylate trials |
|---|---|
| Clinical trials in China | 2 |
A trial with sites in more than one country appears in each of those registers.
Everything on this page is copied from public ClinicalTrials.gov registry records — it is not written from memory, and nothing here describes how Remimazolam Besylate works or whether it is effective. Each trial links to its own record so you can check it yourself.
This page is built automatically: a daily sync job reads the registry records behind our country trial registers, collects every trial that lists Remimazolam Besylate (or a registered synonym) as a drug or biological intervention, and tabulates the registry fields directly. Placebos and generic comparators are excluded. There is no AI drafting and no per-compound editorial pass, and the page has not been clinically reviewed. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The ClinicalTrials.gov data on this page was last retrieved on 24 Sep 2026.